In the last five years, we demonstrated that deregulated expression, phosphorylation of S9 and Y216, and GSK3β activity are distinct features of gastrointestinal cancers including pancreatic cancers and glioblastoma, and that GSK3β sustains the survival and proliferation of these tumor cells. The gene discussed is GSK3B; the disease is familial pancreatic carcinoma.